HIGHFDA DRUG

Ascend Laboratories Recalls Atorvastatin Calcium 80 mg Tablets (90-Count & 500-Count) for Failed Dil

Ascend Laboratories recalls Atorvastatin Calcium Tablets USP, 80 mg, in 90-count and 500-count packages nationwide. The recall cites failed dissolution specifications. Health care providers and patients should stop using the recalled tablets and seek guidance from Ascend or their prescribers.

Official notice
Ascend LaboratoriesHealth & Personal CareDrugs & MedicationsLot#: 25140249Exp. Dec. 2026 Lot#: 25140247Exp. Dec. 2026 Lot#: 24144999

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 19, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
September 19, 2025
Hazard Level
HIGH
Brand
Ascend Laboratories
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Ascend Laboratories
Product type
Atorvastatin Calcium Tablets 80 mg
Model numbers
Lot#: 25140249, Exp. Dec. 2026 Lot#: 25140247, Exp. Dec. 2026 Lot#: 24144999, Exp. Nov. 2026 Lot#: 24144942, Exp. Nov. 2026 Lot#: 24144845, Exp. Nov. 2026 Lot#: 24144713, Exp. Nov. 2026 Lot#: 24144652, Exp. Oct. 2026 Lot#: 24143898 +3 more
UPC codes
67877-511, 67877-512, 67877-513, 67877-514, 67877-511-90, 67877-511-05, 67877-511-10, 67877-511-55 +6 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 19, 2025

  2. Reported by FDA DRUG

    October 22, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Ascend Laboratories, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Atorvastatin Calcium is a prescription statin used to lower cholesterol. Patients obtain this medication through pharmacies under physician guidance.

Why This Is Dangerous

If the tablet does not dissolve properly, the amount of active drug released can be inconsistent, potentially reducing efficacy or causing unexpected dosing.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients may experience reduced cholesterol management effectiveness or require a change in medication. No injuries have been reported in connection with this recall so far.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC: 67877-514-90 or 67877-514-05.
  2. Check Lot numbers listed on the package (e.g., Lot#: 25140249).
  3. Check expiration date on the package (dates through 2026).
  4. Keep packaging until instructed by Ascend.

Where to find product info

Recall details available via the FDA enforcement report and Ascend Laboratories communications. Look for the lot numbers and expiration dates on the vial or bottle label.

What timeline to expect

The recall notice does not specify a refund or replacement timeline. Expect follow-up communications from Ascend Laboratories.

If the manufacturer is unresponsive

  • Document all communications with Ascend Laboratories.
  • File a complaint with the FDA if the company is unresponsive.
  • Keep receipts and packaging for documentation.

How to prevent similar issues

  • Always verify NDC, lot number, and expiration date before dispensing or consuming any medication.
  • Ask your pharmacist about any recalls on prescribed medications.
  • Register recall updates with your pharmacy or healthcare provider to receive immediate notifications.

Documentation advice

Retain Recall notification, original packaging, and all correspondence. Photograph the packaging and vial label for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

NDC 67877-514-90 (90-count) and NDC 67877-514-05 (500-count). Manufacturer: Alkem Laboratories, Ltd. India. Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054. Generic: Atorvastatin Calcium. Brand: Atorvastatin Calcium. Distribution: U.S. Nationwide. Recall date: 2025-09-19. Status: Active.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 90-count and 500-count packages
  • Country of manufacture: India
  • Distribution: Nationwide in the U.S.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot#: 25140249
Exp. Dec. 2026 Lot#: 25140247
Exp. Dec. 2026 Lot#: 24144999
Exp. Nov. 2026 Lot#: 24144942
Exp. Nov. 2026 Lot#: 24144845
+6 more
UPC Codes
67877-511
67877-512
67877-513
+11 more
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls